(Feb. 19, 2018) — The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from Siemens Healthineers that significantly reduces the time required to perform comprehensive diagnostic exams of the knee.
GOKnee3D enables a push-button diagnostic 3D knee exam in just 10 minutes – a substantial reduction from the standard MR knee examination.1 Acquisition of high-resolution isotropic 3D images enables flexible evaluation of these images in all planes, including double oblique and curved planar.
The volume acquisition of GOKnee3D enables higher scan speeds and optimal image reconstruction with better signal quality than in previous technologies. Supported by dedicated, high-channel Tim 4G knee coils as well as automated field of view adaptation based on machine learning and artificial intelligence, the MRI scanner acquires volume data of the knee joint with the push of a button.
“The commercial availability of the GOKnee3D MRI application enables our customers to dramatically accelerate MR imaging of the knee without compromising on diagnostic quality,” said Murat Gungor, Vice President of Magnetic Resonance Imaging at Siemens Healthineers North America. “Faster scanning will help our customers shorten both exam and patient wait times in support of an overall improved patient experience.”
GOKnee3D is available for the MAGNETOM Aera 1.5T and the MAGNETOM Skyra 3T MRI scanners, with eventual rollout planned for additional scanners in the company’s MRI portfolio.
¹Examination time for 3T systems is 10 minutes; for a 1.5T system, up to 11 minutes. All given examination times are examination only; adjustments have been excluded. Applies to measurements only with 15channel knee coil.
View original article on Siemens Healthineers website.
Contact for Journalists
Jeff Bell
Siemens Healthineers
Phone: (484) 868-8346; Email: jeffrey.t.bell@siemens-healthineers.com
Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to achieve better outcomes at lower costs by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.
In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.8 billion and profit of €2.5 billion and has about 48,000 employees worldwide. Further information is available at www.siemens.com/healthineers.
Cassling strengthens community healthcare through customer-centric imaging and therapeutic technology, services and solutions. From critical access hospitals and diagnostic imaging centers to large health systems and IDNs, Cassling is committed to helping healthcare organizations improve access and outcomes, create efficiencies and lower costs.
Comments